MITK
Software - Application · Technology
Chief Accounting Officer
2023-02-01–present
Board Member
Vicarious Surgical Inc. (RBOT)Chief Accounting Officer
Mitek Systems Inc (MITK)Equibles does not estimate personal net worth.
Get an email with a short summary when Vicarious Surgical Inc. publishes a filing, an earnings call transcript or a press release.
Get RBOT alertsFuad Ahmad is recorded as Board Member at Vicarious Surgical Inc. (RBOT) since June 27, 2025 and Chief Accounting Officer at Mitek Systems Inc (MITK) since February 1, 2023. Fuad Ahmad was last confirmed as CFO at Iridex Corp (IRIX) in a filing dated April 29, 2024. Vicarious Surgical Inc. reported in an 8-K filed July 21, 2026 that Fuad Ahmad resigned as member of the Board. Vicarious Surgical Inc. reported in an 8-K filed December 3, 2025 that Fuad Ahmad was appointed member of the Compensation Committee of the Board, effective December 1, 2025. Vicarious Surgical Inc. reported in an 8-K filed June 30, 2025 that Fuad Ahmad was appointed Board of Directors, effective June 27, 2025. Equibles holds 5 filed executive changes naming Fuad Ahmad; each is listed under recent activity with its source filing. The proxy statement of Iridex Corp reports total compensation of $133,200 for Fuad Ahmad in fiscal 2025, including a base salary of $133,200. Disclosed compensation is on record for 6 fiscal years. Fuad Ahmad has spoken on 18 earnings calls across 2 companies, most recently for Iridex Corp on November 12, 2024. Those appearances were for Iridex Corp (IRIX) and Mitek Systems Inc (MITK). Mitek Systems Inc is classified in the Software - Application industry within the Technology sector. Vicarious Surgical Inc. is classified in the Medical Devices industry within the Healthcare sector. Other companies whose calls Fuad Ahmad spoke on are classified in the Healthcare sector. Other leadership on record at Mitek Systems Inc includes Edward H. West (CEO and Board Member), Edward West (CEO and Board Member), James B. DeBello (CEO) and 7 others.
“On July 21, 2026, each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).”
“Joseph Doherty was appointed as a member of the Audit Committee of the Board, Fuad Ahmad was appointed as a member of the Compensation Committee of the Board (the "Compensation Committee"), and Victoria Carr-Brendel was appointed as Chair of the Compensation Committee, in each case effective as of the Effective Date.”
“I would like to begin by reviewing our financial performance for the third quarter ended September 28, 2024. Total revenue in the third quarter of fiscal '24 was $11.6 million, representing a 10% decline compared to $12.9 million in the same period of the prior year.”
“I would like to begin by reviewing our financial performance for the second quarter ended June 29, 2024.”
“I would like to begin by reviewing our financial performance for the first quarter ended March 30, 2024. Total revenue for the first quarter of fiscal 2024 was $11.8 million, down $1.9 million from the prior year period.”
“I would like to begin by reviewing our financial performance for the fourth quarter, followed by our full-year fiscal 2023 results ended December 30, 2023. Fourth quarter total revenue generated was $12.5 million, down $2.7 million from the prior year period.”
“I would like to begin by reviewing our financial performance for Q3 of fiscal 2023. Let me start by providing a high-level summary. We generated $12.9 million in total revenue in Q3, which was flat sequentially versus Q2, important because it is typically a seasonally lower quarter.”
SEC 8-K
2025-12-01–present
2025-06-27–present
2023-02-01–present
Start not stated–2023-08-22
Last confirmed by a filing; no departure on record
Start not stated–2024-04-29
Last confirmed by a filing; no departure on record
Start not stated–2026-07-21
MITK
Software - Application · Technology
Chief Accounting Officer
2023-02-01–present
Medical Devices · Healthcare
Board Member
2025-06-27–present
IRIX
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Iridex Corp (IRIX) | Former Interim Chief Financial Officer | $133,200 | $133,200 |
| 2024 | Mitek Systems Inc (MITK) | Former Interim Chief Financial Officer | $1,016,288 | $1,016,288 |
| 2024 | Iridex Corp (IRIX) | Former Interim Chief Financial Officer | $868,810 | $868,810 |
| 2023 | Mitek Systems Inc (MITK) | Former Interim Chief Financial Officer | $1,156,383 | $1,156,383 |
| 2023 | Iridex Corp (IRIX) | Former Interim Chief Financial Officer | $356,835 | $356,835 |
| 2022 | Iridex Corp (IRIX) | Interim Chief Financial Officer | $424,900 | $424,900 |
| 2021 | Iridex Corp (IRIX) | Interim Chief Financial Officer | $560,400 | $560,400 |
| 2020 | Iridex Corp (IRIX) | Interim Chief Financial Officer | $88,600 | $88,600 |